Find a TenderPast planning notice
Published 15 Nov 2024, 12:23 GMT

Official UK procurement notice

Supply and Support of HLA Rapid Typing Systems

Official notice

Authority: NHS Blood and Transplant (Central government)

2 lotsGoods
Sectors: Medical Devices & Pharma (33) Delivery: UK
Planned pipeline value£800,000total for 2 lots · pipeline notice, not a live tender
Tender notice expected 1 Feb 2026from the planned procurement notice
Lots 2see the lot list below

What is being bought2 lots · detail below

Published requirement description

Supply and Support of HLA Rapid Typing Systems

CPV: Medical equipments · Medical equipments, pharmaceuticals and personal care products

Lots and requirements (2)Procurement structure

2 lots · no lot values published

Procedure terms & legal framework

From the official record · publisher note attached
Legal basis
CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category
Goods
Notice status
Past planning notice
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Stand-alone contract (no framework)
Competition type
Competitive procedure
GPA / WTO covered
Yes (GPA)
Recurring procurement
Unspecified in notice
First published
15 Nov 2024, 12:23 GMT
Last source update
15 Nov 2024, 12:23 GMT
FTS notice number
2024/S 000-037005
Classification (CPV)
Medical equipmentsMedical equipments, pharmaceuticals and personal care products
Delivery area
UK
Official registry OCID
ocds-h6vhtk-04b6ce Find a Tender

Publisher note: Supply and Support of HLA Rapid Typing Systems<br/><br/>NHS Blood & Transplant (NHSBT) Histocompatibility & Immunogenetics function intends to undertake a tender exercise for the supply and support Human Leukocyte Antigen (HLA)rapid typing systems suitable for acute clinical work. <br/><br/>Histocompatibility & Immunogenetics (H&I) is a strategic business function of NHSBT, that provides a portfolio of testing, advice and support in transplantation, platelet refractoriness and transfusion reactions.<br/><br/>Services are supplied through a national network of six laboratories across England. We would like to work with future suppliers of choice to perform HLA rapid typing system in an efficient, timely and cost-effective manner to meet the demands and expectations of our customers and the patients we serve.<br/><br/>Prior to commencing a formal procurement process and to help inform our strategy, NHSBT is seeking to engage with suppliers of commercially available HLA rapid typing systems. NHSBT would like to improve our knowledge of all current and future systems available in the marketplace. This will aid identification of opportunities and gauge market interest in this field.<br/><br/>We require HLA rapid typing system(s) to cover the following:<br/>• The solution must detect, as a minimum, all alleles of the HLA-A, B, C, DRB1, DRB3/4/5,DQA1, DQB1, DPA1 and DPB1 loci as defined in: <br/>o Minimum typing requirements for reporting donor and recipient HLA types.<br/>o HLA Conversion Chart for Organ Allocation.<br/>• The solution must comprise of the essential kits and associated consumables to obtain a result and positive identification of samples throughout the process. <br/>From test material addition to the availability of an interpreted results the turnaround time should be less than three hours. <br/><br/>In addition, we are also interested in technology that can:<br/>• Provide 2nd field HLA type at the above loci <br/>• In under 6 hours<br/><br/>NB: Procurement of the above systems will be tendered by different lots e.g. Lot 1 kits &consumables, lot 2 equipment and maintenance. Please note the equipment will be selected by the compatibility with the chosen kits). <br/><br/>Respondents will be invited to pre-procurement engagement meetings on the 13th, 14th, 27th and/or 28th January 2025 these will be held remotely. To enable NHSBT to finalise arrangements (e.g. send meeting details and agree time slots) for the supplier engagement meetings, interested organisations are required to send an expression of interest via email to [email protected] by no later than 17:00 hrs (GMT) on 16/12/2024. This should include a list of your potential attendees and a brief overview (or a website link) of the Goods /Services which might be offered. Please include options, if available, to offer a managed service contract. <br/><br/>No business whatsoever is guaranteed under any resulting framework agreement or contract,and there is no guarantee that any framework agreement or contract will be put in place in relation to this notice. No compensation etc. will be paid if a tender or resulting framework agreement is withdrawn for any reason. Bidders should take part in this process only on the basis that they fully understand and accept this position. <br/><br/>It should be noted that this procurement exercise may allow other Health authorities to utilise any contracts/ framework agreements awarded.

How it was run

Official notice
Run through: portal not identified

Tender documents are also served through a separate tool: https://health-family.force.com/s/Welcome ↗

Submission deadline
—

Timeline

15 Nov 2024 → 1 Feb 2026 · 2 dates
  1. Notice published
    15 Nov 2024, 12:23 GMT
  2. Tender notice expected272 days ago
    1 Feb 2026

Commercial outcome & contract awards

Pipeline notice
Awards (0)
No award published
Contracts (0)
No contract published
Bid statistics
No aggregate bid statistics published

Contracting authority & participating public bodies

NHS Blood and Transplant

Contracting authorityCentral GovernmentBody governed by public lawHealth 500 North Bristol Park, Bristol, South West, BS34 7QHContact name, email, phone

Official documents & specifications

Official links; attachments are not copied

No document links were published on the notice.